Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events: The REGICOR study

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 357-363

  Velescu, A ^a,b   Clara, A ^a   Penafiel J ^a   Ramos, R ^c,d,e   Marti, R ^b,c   Grau, M ^a   Degano I R ^a   Marrugat, J ^a   Elosua, R ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c IDIAP Jordi Gol   (Spain)

^d Primary Care Research Institute (IDIAP Jordi Gol)   (Spain)

^e UNIVERSITY OF GIRONA   (Spain)

Author keywords

Ankle brachial index; Cardiovascular risk; Risk function

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ANGINA PECTORIS; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CORONARY RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DECISION SUPPORT SYSTEM; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SPAIN; TIME FACTOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS;

EID: 84936791593     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.017     Document Type: Article

References (40)

1. Perk J., De Backer G., Gohlke H., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012, 33:1635-1701.
2. Goff D.C., Lloyd-Jones D.M., Bennett G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014, 129:S49-S73.
3. Brindle P., Beswick A.D., Fahey T., et al. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006, 92:1752-1759.
4. Marrugat J., Vila J., Baena-Díez J.M., et al. Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study. Rev. Esp. Cardiol. 2011, 64:385-394.
5. Elosua R. Cardiovascular risk functions: usefulness and limitations. Rev. Esp. Cardiol. 2014, 67:77-79.
6. Hlatky M.A., Greenland P., Arnett D.K., et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009, 119:2408-2416.
7. Newman A.B., Shemanski l, Manolio T.A., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler. Thromb. Vasc. Biol. 1999, 19:538-545.
8. Lee A.J., Price J.F., Russell M.J., Smith F.B., van Wijk M.C., Fowkes F.G. Improved prediction of fatal myocardial infarction using the ankle brachial Index in addition to Conventional risk factors. The Edinburgh artery study. Circulation 2004, 110:3075-3080.
9. Hooi J.D., Kester A.D., Stoffers H.E., Rinkens P.E., Knottnerus J.A., van Ree J.W. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J. Clin. Epidemiol. 2004, 57:294-300.
10. O'Hare A.M., Katz R., Shlipak M.G., Cushman M., Newman A.B. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 2006 Jan 24, 113:388-393.
11. Smith G.D., Shipley M.J., Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 1990, 82:1925-1931.
12. Leng G.C., Lee A.J., Fowkes F.G., et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 1996, 25:1172-1181.
13. Kornitzer M., Dramaix M., Sobolski J., Degre S., De Backer G. Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology 1995, 46:211-219.
14. Newman A.B., Sutton-Tyrrell K., Vogt M.T., Kuller L.H. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. J. Am. Med. Assoc. 1993, 270:487-489.
15. Merino J., Planas A., De Moner A., et al. The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence. Eur. J. Vasc. Endovasc. Surg. 2008, 36:71-76.
16. Fowkes F.G., Murray G.D., Butcher I., et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. J. Am. Med. Assoc. 2008, 300:197-208. Ankle Brachial Index Collaboration.
17. Rodondi N., Marques-Vidal P., Butler J., et al. Health, aging, and body composition study. Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults. Am. J. Epidemiol. 2010, 171:540-549.
18. Yeboah J., McClelland R.L., Polonsky T.S., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. J. Am. Med. Assoc. 2012, 308:788-795.
19. Kavousi M., Elias-Smale S., Rutten J.H.W., et al. Evaluation of newer risk markers for coronary heart disease risk classification. A cohort study. Ann. Intern. Med. 2012, 156:438-444.
20. Murphy T.P., Dhangana R., Pencina M.J., D'Agostino R.B. Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. Atherosclerosis 2012, 220:160-167.
21. Fowkes F.G.R., Murray G.D., Butcher I., et al. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur. J. Prev. Cardiol. 2014, 21:310-320.
22. Lin J.S., Olson C.M., Johnson E.S., Whitlock E.P. The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. preventive services task force. Ann. Intern. Med. 2013, 159:333-341.
23. Grau M., Subirana I., Elosua R., et al. Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain. Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14:653-659.
24. Ramos R., Quesada M., Solanas P., et al. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur. J. Vasc. Endovasc. Surg. 2009, 38:305-311.
25. Manual of the MONICA Project (Manual on the Internet) 2000, World Health Organization, Geneva, Available from:. http://www.ktl.fi/publications/monica/manual/index.htm.
26. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
27. Marrugat J., D'Agostino R., Sullivan L., et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J. Epidemiol. Community Health 2003, 57:634-638.
28. Marrugat J., Subirana I., Comín E., et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J. Epidemiol. Community Health 2007, 61:40-47. Erratum in: J Epidemiol Community Health. 2007;61:655.
29. Luepker R.V., Apple F.S., Christenson R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003, 108:2543-2549.
30. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993, 24:35-41.
31. Newson R. Confidence intervals for rank statistics: Somers' D and extensions. Stata J. 2006, 6:309-334.
32. Pencina M.J., D'Agostino R.B., Steyerberg E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med. 2011, 30:11-21.
33. Steyerberg E.W., Pencina M.J. Reclassification calculations for persons with incomplete follow-up. Ann. Intern. Med. 2010, 152:195-196.
34. R: A Language and Environment for Statistical Computing R Foundation for Statistical Computing, Vienna, Austria.
35. Alzamora M.T., Forés R., Pera G., et al. Ankle-brachial index and the incidence of cardiovascular events in the Mediterranean low cardiovascular risk population ARTPER cohort. BMC Cardiovasc. Disord. 2013, 13:119.
36. Ramos R., Baena-Díez J.M., Quesada M., et al. Derivation and validation of REASON: a risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index. Atherosclerosis 2011, 214:474-479.
37. Leening M.J., Vedder M.M., Witteman J.C., Pencina M.J., Steyerberg E.W. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. Ann. Intern. Med. 2014, 160:122-131.
38. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur. J. Vasc. Endovasc. Surg. 2007, 33:S1-S75.
39. Aboyans V., Criqui M.H., Abraham P., et al. Measurement and interpretation of the Ankle-Brachial Index. Circulation 2012, 126:2890-2909.
40. Lobos J.M., Galve E., Royo-Bordonada M.A., et al. Posicionamiento del Comité Español Interdisciplinario de Prevención Cardiovascular y la Sociedad Española de Cardiología en el tratamiento de las dislipemias. Divergencia entre las guías europea y estadounidense. Rev. Esp. Cardiol. 2014, 67:913-919.